All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

43

Reset

43 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • ZasocitinibTAK- 279, NDI-034858Phase 317 trials

    Takeda · Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease

  • AfimkibartRO7790121, RVT-3101Phase 312 trials

    Roche (Genentech) · Moderately to Severely Active Ulcerative Colitis, Moderately to Severely Active Crohns Disease, Atopic Dermatitis

  • MK-7240PRA023, TulisokibartPhase 310 trials

    Merck & Co. · Ulcerative Colitis, Psoriatic Arthritis, Crohn's Disease

  • LutikizumabABT-981Phase 38 trials

    AbbVie · Hidradenitis Suppurativa, Atopic Dermatitis, Rheumatoid Arthritis

  • DuvakitugSAR447189, TEV-48574 APhase 36 trials

    Sanofi · Ulcerative Colitis, Crohn's Disease, Hidradenitis

  • FilgotinibGS-6034, GLPG0634Phase 36 trials

    Alfasigma S.p.A. · Ulcerative Colitis, Polyarticular Course Juvenile Idiopathic Arthritis, Juvenile Idiopathic Arthritis (JIA)

  • ABX464ObefazimodPhase 35 trials

    Abivax S.A. · Ulcerative Colitis, Moderately to Severely Active Crohn Disease

  • Hemay005Mufemilast, Phosphodiesterase 4 inhibitorsPhase 34 trials

    Ganzhou Hemay Pharmaceutical Co., Ltd · Moderate to Severe Ulcerative Colitis, Ulcerative Colitis (UC), COPD (Chronic Obstructive Pulmonary Disease)

  • JNJ-78934804JNJ-4804Phase 34 trials

    Johnson & Johnson (Janssen) · Colitis, Ulcerative, Crohn's Disease, Crohn Disease

  • brivekimigSAR442970Phase 25 trials

    Sanofi · Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion, Type 1 Diabetes Mellitus

  • SHR-1139Phase 25 trials

    Guangdong Hengrui Pharmaceutical Co., Ltd · Moderate to Severe Plaque Psoriasis, Palmoplantar Pustulosis of Adults, Pyoderma Gangrenosum

  • MORF-057zotemtegrast, LY4268989Phase 24 trials

    Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) · Inflammatory Bowel Diseases, Crohn's Disease, Ulcerative Colitis (UC)

  • IPG11406Phase 23 trials

    Nanjing Immunophage Biotech Co., Ltd · Lupus Nephritis, Moderately to Severely Active Ulcerative Colitis (UC)

  • ABBV-701Phase 22 trials

    AbbVie · Crohn's Disease, Ulcerative Colitis, Psoriatic Arthritis

  • Biocad · Ulcerative Colitis (UC), Crohn's Disease (CD)

  • EltrekibartLY3041658Phase 22 trials

    Eli Lilly · Ulcerative Colitis, Ulcerative Colitis Chronic, Hidradenitis Suppurativa

  • HSK47388Phase 22 trials

    Haisco Pharmaceutical Group Co., Ltd. · Plaque Psoriasis, Ulcerative Colitis (UC)

  • LY4395089Phase 22 trials

    Eli Lilly · Crohn Disease, Colitis, Ulcerative

  • RosnilimabANB030Phase 22 trials

    AnaptysBio, Inc. · Rheumatoid Arthritis, Ulcerative Colitis

  • SPY001SPY001-001Phase 22 trials

    Spyre Therapeutics, Inc. · Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis

  • SPY002SPY002-091Phase 22 trials

    Spyre Therapeutics, Inc. · Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis

  • SPY003SPY003-207Phase 22 trials

    Spyre Therapeutics, Inc. · Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis

  • TrosunilimabABBV-382Phase 22 trials

    AbbVie · Crohn's Disease, Ulcerative Colitis

  • ABBV-668Phase 21 trial

    AbbVie · Ulcerative Colitis

  • ALTB-268Phase 21 trial

    AltruBio Inc. · Ulcerative Colitis

  • ATH-063Phase 21 trial

    Athos Therapeutics Inc · Ulcerative Colitis, Inflammatory Bowel Diseases, Autoimmune Diseases

  • BGP-014Phase 21 trial

    BioGaia Pharma AB · Ulcerative Colitis

  • BI 3032950Phase 21 trial

    Boehringer Ingelheim · Ulcerative Colitis

  • GarutadustatISM5411Phase 21 trial

    InSilico Medicine Hong Kong Limited · Ulcerative Colitis

  • HRS-7085Phase 21 trial

    Shandong Suncadia Medicine Co., Ltd. · Adult Patients With Moderately to Severely Active Ulcerative Colitis

  • INT-210Phase 21 trial

    Innatus Therapeutics (Shanghai) Co., Ltd. · Ulcerative Colitis (UC)

  • MB-001Phase 21 trial

    Mage Biologics · Ulcerative Colitis (UC)

  • MGT-006Phase 21 trial

    Metagen Therapeutics, Inc. · Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate

  • MK-8690PRA052Phase 21 trial

    Merck & Co. · Colitis Ulcerative, Ulcerative Colitis

  • MT-201Phase 21 trial

    Mirador Therapeutics, Inc. · Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn's Disease

  • MT-501Phase 21 trial

    Mirador Therapeutics, Inc. · Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn's Disease

  • OD-07656Phase 21 trial

    Odyssey Therapeutics, Inc. · Ulcerative Colitis (UC), UC - Ulcerative Colitis

  • PALI-2108Phase 21 trial

    Palisade Bio · Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis

  • PL8177Active study medicationPhase 21 trial

    Palatin Technologies, Inc · Ulcerative Colitis, Ulcerative Colitis Acute, Ulcerative

  • PTT-621Phase 21 trial

    Pyrotech Therapeutics, Inc. · Ulcerative Colitis (UC)

  • RO7837195Phase 21 trial

    Roche (Genentech) · Ulcerative Colitis

  • SAR443122Phase 21 trial

    Sanofi · Colitis Ulcerative

  • XmAb942Phase 21 trial

    Xencor, Inc. · Ulcerative Colitis (UC)

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.